Ke Ma

Title: Ke Ma - Innovator in Tumor Treatment

Introduction

Ke Ma is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of medicine, particularly in the development of innovative treatments for tumors. His work focuses on combining different inhibitors to enhance therapeutic efficacy.

Latest Patents

Ke Ma holds a patent for the "Use of EZH2 inhibitor combined with BTK inhibitor in preparing drug for treating tumor." This application describes a novel approach that utilizes an EZH2 inhibitor in conjunction with a BTK inhibitor to create a drug aimed at treating tumors. This innovative combination has the potential to improve treatment outcomes for patients suffering from various types of cancer.

Career Highlights

Ke Ma is associated with Jiangsu Hengrui Medicine Company Ltd., a leading pharmaceutical company in China. His role at the company allows him to engage in cutting-edge research and development, contributing to advancements in cancer treatment. His expertise and dedication have positioned him as a key figure in the field of oncology.

Collaborations

Ke Ma has collaborated with notable colleagues, including Guoqing Cao and Changyong Yang. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, ultimately leading to innovative solutions in cancer therapy.

Conclusion

Ke Ma's contributions to the field of tumor treatment through his innovative patent demonstrate his commitment to advancing medical science. His work at Jiangsu Hengrui Medicine Company Ltd. and collaborations with esteemed colleagues highlight the importance of teamwork in achieving breakthroughs in healthcare.